Answers are grounded in this paper and cite their sources.
There have been limited data on the changes in clinical outcomes after the introduction of direct oral anticoagulants (DOACs) for venous thromboembolism (VTE) in real clinical practice. We evaluated the changes in management strategies and long-term outcomes from the warfarin era to the DOAC era.
No takes yet. Share an insight, caveat, or question.
Kaneda et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: